Skip to content
Open access · CC-BY via OpenAlex

Gut Microbiome Changes in Gestational Diabetes

Ruxandra Florentina Ionescu, Robert Mihai Enache, Sanda Maria Creţoiu, Bogdan Severus Gașpar

International Journal of Molecular Sciences · 2022 · ▲ 64 citations

Abstract

Gestational diabetes mellitus (GDM), one of the most common endocrine pathologies during pregnancy, is defined as any degree of glucose intolerance with onset or first discovery in the perinatal period. Physiological changes that occur in pregnant women can lead to inflammation, which promotes insulin resistance. In the general context of worldwide increasing obesity in young females of reproductive age, GDM follows the same ascending trend. Changes in the intestinal microbiome play a decisive role in obesity and the development of insulin resistance and chronic inflammation, especially in patients with type 2 diabetes mellitus (T2D). To date, various studies have also associated intestinal dysbiosis with metabolic changes in women with GDM. Although host metabolism in women with GDM has not been fully elucidated, it is of particular importance to analyze the available data and to discuss the actual knowledge regarding microbiome changes with potential impact on the health of pregnant women and newborns. We analyzed peer-reviewed journal articles available in online databases in order to summarize the most recent findings regarding how variations in diet and metabolic status of GDM patients can contribute to alteration of the gut microbiome, in the same way that changes of the gut microbiota can lead to GDM. The most frequently observed alteration in the microbiome of patients with GDM was either an increase of the Firmicutes phylum, respectively, or a decrease of the Bacteroidetes and Actinobacteria phyla. Gut dysbiosis was still present postpartum and can impact the development of the newborn, as shown in several studies. In the evolution of GDM, probiotic supplementation and regular physical activity have the strongest evidence of proper blood glucose control, favoring fetal development and a healthy outcome for the postpartum period. The current review aims to summarize and discuss the most recent findings regarding the correlation between GDM and dysbiosis, and current and future methods for prevention and treatment (lifestyle changes, pre- and probiotics administration). To conclude, by highlighting the role of the gut microbiota, one can change perspectives about the development and progression of GDM and open up new avenues for the development of innovative therapeutic targets in this disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms232112839
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Ionescu, R.F., Enache, R.M., Creţoiu, S.M., &amp; Gașpar, B.S. (2022). Gut Microbiome Changes in Gestational Diabetes. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms232112839
Vancouver
Ionescu RF, Enache RM, Creţoiu SM, Gașpar BS. Gut Microbiome Changes in Gestational Diabetes. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms232112839.
BibTeX
@article{ruxandra2022GutMic, title = {Gut Microbiome Changes in Gestational Diabetes}, author = {Ruxandra Florentina Ionescu and Robert Mihai Enache and Sanda Maria Creţoiu and Bogdan Severus Gașpar}, journal = {International Journal of Molecular Sciences}, year = {2022}, doi = {10.3390/ijms232112839}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings